• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特异性促解决脂质介质:血管重构的新治疗方法。

Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.

机构信息

Departamento de Farmacología, Instituto de Investigación Hospital La Paz, Universidad Autónoma de Madrid, 28029 Madrid, Spain.

Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain.

出版信息

Int J Mol Sci. 2022 Mar 25;23(7):3592. doi: 10.3390/ijms23073592.

DOI:10.3390/ijms23073592
PMID:35408952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8998739/
Abstract

Vascular remodeling is a typical feature of vascular diseases, such as atherosclerosis, aneurysms or restenosis. Excessive inflammation is a key mechanism underlying vascular remodeling via the modulation of vascular fibrosis, phenotype and function. Recent evidence suggests that not only augmented inflammation but unresolved inflammation might also contribute to different aspects of vascular diseases. Resolution of inflammation is mediated by a family of specialized pro-resolving mediators (SPMs) that limit immune cell infiltration and initiate tissue repair mechanisms. SPMs (lipoxins, resolvins, protectins, maresins) are generated from essential polyunsaturated fatty acids. Synthases and receptors for SPMs were initially described in immune cells, but they are also present in endothelial cells (ECs) and vascular smooth muscle cells (VSMCs), where they regulate processes important for vascular physiology, such as EC activation and VSMC phenotype. Evidence from genetic models targeting SPM pathways and pharmacological supplementation with SPMs have demonstrated that these mediators may play a protective role against the development of vascular remodeling in atherosclerosis, aneurysms and restenosis. This review focuses on the latest advances in understanding the role of SPMs in vascular cells and their therapeutic effects in the vascular remodeling associated with different cardiovascular diseases.

摘要

血管重构是血管疾病(如动脉粥样硬化、动脉瘤或再狭窄)的典型特征。过度炎症是通过调节血管纤维化、表型和功能导致血管重构的关键机制。最近的证据表明,不仅增强的炎症,而且未解决的炎症也可能导致血管疾病的不同方面。炎症的解决是由一组专门的促解决介质(SPM)介导的,这些介质限制免疫细胞浸润并启动组织修复机制。SPM(脂氧素、解析素、保护素、maresin)是由必需的多不饱和脂肪酸生成的。SPM 的合成酶和受体最初在免疫细胞中描述,但它们也存在于内皮细胞(EC)和血管平滑肌细胞(VSMC)中,在那里它们调节对血管生理学很重要的过程,如 EC 激活和 VSMC 表型。针对 SPM 途径的遗传模型和 SPM 药理学补充的证据表明,这些介质可能在动脉粥样硬化、动脉瘤和再狭窄相关的血管重构的发展中发挥保护作用。本文综述了 SPM 在血管细胞中的作用及其在与不同心血管疾病相关的血管重构中的治疗效果的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/bb9c91f05bcf/ijms-23-03592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/b4e9af8a858f/ijms-23-03592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/4adc641af6de/ijms-23-03592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/170a4b1e7080/ijms-23-03592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/5aecf62f86be/ijms-23-03592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/c3685a21026f/ijms-23-03592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/bb9c91f05bcf/ijms-23-03592-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/b4e9af8a858f/ijms-23-03592-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/4adc641af6de/ijms-23-03592-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/170a4b1e7080/ijms-23-03592-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/5aecf62f86be/ijms-23-03592-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/c3685a21026f/ijms-23-03592-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b17/8998739/bb9c91f05bcf/ijms-23-03592-g006.jpg

相似文献

1
Specialized Pro-Resolving Lipid Mediators: New Therapeutic Approaches for Vascular Remodeling.特异性促解决脂质介质:血管重构的新治疗方法。
Int J Mol Sci. 2022 Mar 25;23(7):3592. doi: 10.3390/ijms23073592.
2
Molecular Pharmacology of Inflammation Resolution in Atherosclerosis.动脉粥样硬化中炎症消退的分子药理学。
Int J Mol Sci. 2022 Apr 27;23(9):4808. doi: 10.3390/ijms23094808.
3
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.E 系列消退素代谢组、专门的促消退介质(SPM)的生物合成及其立体化学在炎症消退中的关键作用:为长期新冠、人体临床试验和靶向精准营养制备 SPM。
Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16.
4
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.利用特异性促解决脂质介质来避免 SARS-COV-2 患者的细胞因子风暴。
Biochem Pharmacol. 2023 Mar;209:115437. doi: 10.1016/j.bcp.2023.115437. Epub 2023 Jan 30.
5
Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis.特异性促解决脂质介质:动脉粥样硬化的潜在治疗靶点。
Int J Mol Sci. 2022 Mar 15;23(6):3133. doi: 10.3390/ijms23063133.
6
The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection.专门的促解决内源性脂质介质、维生素和其他微量营养素在控制炎症过程中的功能:在 SARS-CoV-2 相关感染患者中的可能作用。
Prostaglandins Other Lipid Mediat. 2022 Apr;159:106619. doi: 10.1016/j.prostaglandins.2022.106619. Epub 2022 Jan 12.
7
Pro-resolution therapeutics for cardiovascular diseases.心血管疾病的促消退疗法。
Prostaglandins Other Lipid Mediat. 2017 Sep;132:12-16. doi: 10.1016/j.prostaglandins.2017.03.004. Epub 2017 Apr 24.
8
Specialized pro-resolving mediators in cardiovascular diseases.心血管疾病中的特异性促解决介质。
Mol Aspects Med. 2017 Dec;58:65-71. doi: 10.1016/j.mam.2017.02.003. Epub 2017 Feb 28.
9
Resolution of inflammation in oral diseases.口腔疾病的炎症消退。
Pharmacol Ther. 2023 Jul;247:108453. doi: 10.1016/j.pharmthera.2023.108453. Epub 2023 May 25.
10
Specialized pro-resolving mediator network: an update on production and actions.特异性促解决介质网络:产生和作用的最新研究进展。
Essays Biochem. 2020 Sep 23;64(3):443-462. doi: 10.1042/EBC20200018.

引用本文的文献

1
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.类风湿关节炎与血栓形成的炎症关联:致病分子机制及治疗方法
Curr Issues Mol Biol. 2025 Apr 18;47(4):291. doi: 10.3390/cimb47040291.
2
Fish-derived biomaterials for tissue engineering: advances in scaffold fabrication and applications in regenerative medicine and cancer therapy.用于组织工程的鱼类衍生生物材料:支架制造的进展以及在再生医学和癌症治疗中的应用
Theranostics. 2025 Apr 21;15(12):5666-5692. doi: 10.7150/thno.109186. eCollection 2025.
3
Role of Inflammatory and Proresolving Mediators in Endothelial Dysfunction.

本文引用的文献

1
E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.E 系列消退素代谢组、专门的促消退介质(SPM)的生物合成及其立体化学在炎症消退中的关键作用:为长期新冠、人体临床试验和靶向精准营养制备 SPM。
Semin Immunol. 2022 Jan;59:101597. doi: 10.1016/j.smim.2022.101597. Epub 2022 Feb 16.
2
GPR18-Mediated Relaxation of Human Isolated Pulmonary Arteries.GPR18 介导的人离体肺动脉舒张。
Int J Mol Sci. 2022 Jan 26;23(3):1427. doi: 10.3390/ijms23031427.
3
炎症和促消退介质在内皮功能障碍中的作用。
Basic Clin Pharmacol Toxicol. 2025 May;136(5):e70026. doi: 10.1111/bcpt.70026.
4
TAM receptors mediate the Fpr2-driven pain resolution and fibrinolysis after nerve injury.TAM 受体介导神经损伤后 Fpr2 驱动的疼痛缓解和纤维蛋白溶解。
Acta Neuropathol. 2024 Dec 16;149(1):1. doi: 10.1007/s00401-024-02840-9.
5
Control of inflammatory lung injury and repair by metabolic signaling in endothelial cells.内皮细胞中代谢信号对炎症性肺损伤的控制与修复
Curr Opin Hematol. 2025 May 1;32(3):157-167. doi: 10.1097/MOH.0000000000000848. Epub 2024 Oct 25.
6
Aspirin treatment for unruptured intracranial aneurysms: Focusing on its anti-inflammatory role.阿司匹林治疗未破裂颅内动脉瘤:聚焦其抗炎作用。
Heliyon. 2024 Apr 4;10(7):e29119. doi: 10.1016/j.heliyon.2024.e29119. eCollection 2024 Apr 15.
7
Increased Hepatocyte Growth Factor Secretion by Placenta-Derived Mesenchymal Stem Cells Improves Ovarian Function in an Ovariectomized Rat Model via Vascular Remodeling by Wnt Signaling Activation.胎盘来源间充质干细胞通过 Wnt 信号激活促进血管重塑增加肝细胞生长因子分泌从而改善卵巢切除大鼠模型的卵巢功能。
Cells. 2023 Nov 25;12(23):2708. doi: 10.3390/cells12232708.
8
Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.利用特异性促解决脂质介质来避免 SARS-COV-2 患者的细胞因子风暴。
Biochem Pharmacol. 2023 Mar;209:115437. doi: 10.1016/j.bcp.2023.115437. Epub 2023 Jan 30.
9
Eicosanoids in inflammation in the blood and the vessel.血液和血管炎症中的类二十烷酸。
Front Pharmacol. 2022 Sep 27;13:997403. doi: 10.3389/fphar.2022.997403. eCollection 2022.
10
The Impact of Resolution of Inflammation on Tumor Microenvironment: Exploring New Ways to Control Cancer Progression.炎症消退对肿瘤微环境的影响:探索控制癌症进展的新方法。
Cancers (Basel). 2022 Jul 8;14(14):3333. doi: 10.3390/cancers14143333.
Aortic Wall Inflammation in the Pathogenesis, Diagnosis and Treatment of Aortic Aneurysms.
主动脉壁炎症在主动脉瘤发病机制、诊断和治疗中的作用。
Inflammation. 2022 Jun;45(3):965-976. doi: 10.1007/s10753-022-01626-z. Epub 2022 Jan 25.
4
Lipoxin A and its analog attenuate high fat diet-induced atherosclerosis via Keap1/Nrf2 pathway.脂氧素 A 及其类似物通过 Keap1/Nrf2 通路减轻高脂饮食诱导的动脉粥样硬化。
Exp Cell Res. 2022 Mar 1;412(1):113025. doi: 10.1016/j.yexcr.2022.113025. Epub 2022 Jan 10.
5
Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.促炎消退脂质介质对 T 细胞免疫应答的调节作用。
Front Immunol. 2021 Nov 16;12:768133. doi: 10.3389/fimmu.2021.768133. eCollection 2021.
6
The resolvin D1 receptor GPR32 transduces inflammation resolution and atheroprotection.解析素 D1 受体 GPR32 转导炎症缓解和动脉保护。
J Clin Invest. 2021 Dec 15;131(24). doi: 10.1172/JCI142883.
7
Inflammation during the life cycle of the atherosclerotic plaque.动脉粥样硬化斑块生命周期中的炎症反应。
Cardiovasc Res. 2021 Nov 22;117(13):2525-2536. doi: 10.1093/cvr/cvab303.
8
Chemerin promotes microangiopathy in diabetic retinopathy via activation of ChemR23 in rat primary microvascular endothelial cells.趋化素通过激活大鼠原代微血管内皮细胞中的 ChemR23 促进糖尿病视网膜病变中的微血管病变。
Mol Vis. 2021 Sep 5;27:575-587. eCollection 2021.
9
Maresin 1 activates LGR6 signaling to inhibit smooth muscle cell activation and attenuate murine abdominal aortic aneurysm formation.马尿酸 1 激活 LGR6 信号通路以抑制平滑肌细胞活化并减轻小鼠腹主动脉瘤形成。
FASEB J. 2021 Aug;35(8):e21780. doi: 10.1096/fj.202100484R.
10
Targeting inflammation in atherosclerosis - from experimental insights to the clinic.靶向动脉粥样硬化炎症——从实验研究到临床实践。
Nat Rev Drug Discov. 2021 Aug;20(8):589-610. doi: 10.1038/s41573-021-00198-1. Epub 2021 May 11.